MPLT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $9.82
Market Cap (MRQ) $446M
P/E -0.5
EPS $-18.56
ROE -151.1%
52W Range $9–$40

MPLT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
EPS$-18.56
2024-12-31 → 2025-12-31
Free Cash Flow$-139M
2025-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend MPLT 5Y avg Peer Median Verdict
P/E -0.5 · · ·
P/B (MRQ) 1.3 · 4.7 Fair value
Price / FCF (TTM) -2.5 · · ·
Price / Cash Flow (TTM) -2.6 · · ·
Price / Tangible Book 0.9 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -545.9%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Sep 1, 2026 $-1.32 $-1.34 1.5%
March 31, 2026 May 14, 2026 $-1.34 $-1.12 -20.1%
Dec. 31, 2025 $-2.47 $-0.98 -151.7%
Sept. 30, 2025 $-37.18 $-1.76 -2013.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 12
Metric Trend 20252024
R&D Expense $138M$69M
SG&A Expense $31M$14M
Operating Expenses $169M$83M
Operating Income $-169M$-83M
Interest Income $6M$5M
Other Non-op $2M$2M
Net Income $-161M$-78M
EPS (Basic) $-18.56$-105.38
EPS (Diluted) $-18.56$-105.38
Shares (Basic) 8,680,741736,178
Shares (Diluted) 8,680,741736,178
EBITDA $-169M·
Balance Sheet 20
Metric Trend 20252024
Cash & Equivalents $47M$38M
Short-term Investments $258M$71M
Prepaid Expense $20M$6M
Current Assets $325M$115M
PP&E (Net) $1M$1M
PP&E (Gross) $4M$3M
Accum. Depreciation $3M$2M
Other Non-current Assets $59.0K$3M
Total Assets $480M$137M
Accounts Payable $3M$2M
Accrued Liabilities $12M$10M
Current Liabilities $16M$16M
Capital Leases $5M$6M
Total Liabilities $21M$22M
Common Stock $5.0K$0
Retained Earnings $-361M$-199M
AOCI $-228.0K$163.0K
Stockholders' Equity $458M$-194M
Liabilities + Equity $480M$137M
Shares Outstanding 44,024,088761,276
Cash Flow 6
Metric Trend 20252024
Stock-based Comp $36M$1M
Operating Cash Flow $-138M$-79M
CapEx $473.0K$770.0K
Investing Cash Flow $-323M$-81M
Financing Cash Flow $470M$118M
Free Cash Flow $-139M·
Profitability 2
Metric Trend 20252024
ROA -52.3%·
ROE -151.1%·
Liquidity & Solvency 2
Metric Trend 20252024
Current Ratio 20.0·
Quick Ratio 18.8·
Per Share 4
Metric Trend 20252024
Book Value / Share $10.41·
Cash Flow / Share $-15.91·
Cash / Share $1.06·
EPS (TTM) $-18.56·
Valuation (TTM) 8
Metric Trend 20252024
Net Income TTM $-161M·
Market Cap $773M·
P/E -0.9·
P/B 1.7·
P / Tangible Book 1.7·
P / Cash Flow -5.6·
P / FCF -5.6·
Earnings Yield -105.7%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-31
Net Income $-161M $-78M
Diluted EPS $-18.56 $-105.38

Institutional owners (13F) 109 filers · $805.8M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 109
Value held $805.8M
New positions 39
Exited positions 10
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
39 (+15 vs prior Q) 10 (-3 vs prior Q) 22 (-2 vs prior Q) 28 (+16 vs prior Q) +1.6M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
NOVO HOLDINGS A/S $132,128,532 3,686,622 16.40% Shares
FCPM III SERVICES B.V. $115,634,176 3,226,400 14.35% Shares
GOLDMAN SACHS GROUP INC $69,827,502 1,948,312 8.67% Shares
BlackRock, Inc. $36,740,802 1,025,134 4.56% Shares
Nan Fung Group Holdings Ltd $34,809,708 971,253 4.32% Shares
5AM Venture Management, LLC $34,048,394 950,011 4.23% Shares
Sanofi $32,687,549 912,041 4.06% Shares
STATE STREET CORP $30,541,056 852,150 3.79% Shares
FMR LLC $29,516,247 823,556 3.66% Shares
VANGUARD CAPITAL MANAGEMENT LLC $28,103,936 784,150 3.49% Shares
Blue Owl Capital Holdings LP $26,160,655 729,929 3.25% Shares
Paradigm Biocapital Advisors LP $24,580,936 685,852 3.05% Shares
Pivotal bioVenture Partners Investment Advisor LLC $21,914,225 611,446 2.72% Shares
Velan Capital Investment Management LP $17,665,285 492,893 2.19% Shares
Siren, L.L.C. $16,128,000 450,000 2.00% Shares
VANGUARD GROUP INC $15,275,718 869,668 1.90% Shares
Capital World Investors $14,899,763 415,730 1.85% Shares
GEODE CAPITAL MANAGEMENT, LLC $14,414,363 402,051 1.79% Shares
BAKER BROS. ADVISORS LP $13,071,027 364,705 1.62% Shares
DAFNA Capital Management LLC $6,128,855 171,006 0.76% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $6,123,694 170,862 0.76% Shares
Freestone Grove Partners LP $6,053,806 168,912 0.75% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $4,903,557 136,818 0.61% Shares
MILLENNIUM MANAGEMENT LLC $4,617,661 128,841 0.57% Shares
SUPERSTRING CAPITAL MANAGEMENT LP $4,495,483 125,432 0.56% Shares
VANGUARD FIDUCIARY TRUST CO $4,413,158 123,135 0.55% Shares
UBS Group AG $4,373,484 122,028 0.54% Shares
NORTHERN TRUST CORP $4,180,808 116,652 0.52% Shares
STEMPOINT CAPITAL LP $3,831,511 106,906 0.48% Shares
SEVEN GRAND MANAGERS, LLC $3,584,000 100,000 0.44% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $3,467,914 96,761 0.43% Shares
LAZARD ASSET MANAGEMENT LLC $2,870,139 80,082 0.36% Shares
Boxer Capital Management, LLC $2,688,000 75,000 0.33% Shares
Burkehill Global Management, LP $2,688,000 75,000 0.33% Shares
BNP PARIBAS FINANCIAL MARKETS $2,526,147 70,484 0.31% Shares
Trexquant Investment LP $2,286,305 63,792 0.28% Shares
TD Asset Management Inc $1,954,212 54,526 0.24% Shares
BANK OF AMERICA CORP /DE/ $1,951,990 54,464 0.24% Shares
WELLINGTON MANAGEMENT GROUP LLP $1,860,705 51,917 0.23% Shares
Jain Global LLC $1,632,548 45,551 0.20% Shares
MORGAN STANLEY $1,372,815 38,304 0.17% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $1,254,400 35,000 0.16% Shares
Weiss Asset Management LP $1,186,089 33,094 0.15% Shares
JANUS HENDERSON GROUP PLC $1,113,108 54,752 0.14% Shares
Bank of New York Mellon Corp $1,089,894 30,410 0.14% Shares
ADAR1 Capital Management, LLC $949,652 26,497 0.12% Shares
CITADEL ADVISORS LLC $922,916 25,751 0.11% Shares
Jump Financial, LLC $903,956 25,222 0.11% Shares
XTX Topco Ltd $893,097 24,919 0.11% Shares
Ghisallo Capital Management LLC $716,800 20,000 0.09% Shares

Show all 109 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Catalyst4, Inc., Ekemini Riley, Mark Vorsatz, Robert Brown ×3 filings Aug. 18, 2026 49.90% Amendment · SEC
Novo Holdings A/S ×2 filings July 31, 2026 4.90% Amendment · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 16 insiders · 7 officers · 8 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Christopher A. Kroeger Chief Executive Officer Aug. 17, 2026 A 1,269,600 0 29 $-12,541,740
Jonathan Gillis CAO and Interim CFO Aug. 17, 2026 A 152,482 0 13 $-3,555,885
Vishwas Setia Chief Financial Officer May 6, 2026 S 356,256 0 11 $-1,103,291
Kristopher Hanson General Counsel Sept. 16, 2026 S 137,044 0 19 $-1,657,103
Anatol Kreitzer Chief Discovery Officer Aug. 17, 2026 A 180,926 0 11 $-2,781,198
Erin Pennock Foff Chief Medical Officer Aug. 17, 2026 A 312,261 0 22 $-3,375,583
James Woodruff Lillie Chief Scientific Officer Aug. 17, 2026 A 210,110 0 20 $-2,561,761
Troy Cox Director July 28, 2026 P 15,620 1 0 $148,702
Nanna Liebach Luneborg Director June 23, 2026 A 3,932 0 0 $0
Timothy John Garnett Director June 23, 2026 A 53,457 1 0 $252,678
Maria C Walker Director June 23, 2026 A 62,703 0 0 $0
George Pavlov Director June 23, 2026 A 28,932 3 0 $441,168
Martin Babler Director June 23, 2026 A 7,864 0 0 $0
Robert C. Malenka Director April 15, 2026 S 316,466 0 14 $-1,599,229
Catalyst4, Inc. 10% owner Aug. 14, 2026 P 25,306,689 7 0 $191,215,066
Novo Holdings A/S · Oct. 28, 2025 C 3,686,622 1 0 $16,199,997

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 17 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
BBC · ETFis Series Trust I 0.31% 11,201 NS July 31, 2026 N-PORT
IBRN · iShares Trust 0.11% 593 SH Sept. 11, 2026 Daily
LABU · Direxion Shares ETF Trust 0.04% 16,937 NS July 31, 2026 N-PORT
IWC · iShares Trust 0.03% 36,111 SH Sept. 11, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.02% 9,847 SH Aug. 19, 2026 Daily
PWS · Pacer Funds Trust 0.01% 231 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.01% 216,244 SH Aug. 19, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 60,001 SH Aug. 19, 2026 Daily
IWO · iShares Trust 0.01% 83,819 SH Sept. 11, 2026 Daily
IWM · iShares Trust 0.00% 262,922 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.00% 4,990 NS July 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 552,279 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.00% 1,093 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 892 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.00% 24,928 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 11,152 SH Sept. 11, 2026 Daily
ISCB · iShares Trust · 756 SH Sept. 11, 2026 Daily

MPLT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 20 analysts BUY
Median target $25.00 +154.6%
7 35.0% Strong Buy
10 50.0% Buy
3 15.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

13 analysts · 2026-10-04

Mean target $26.54 +170.2%

← Below all targets Current price $9.82
Low$13.00 Mean$26.54 High$43.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MPLT $773M -0.9 · · -151.1% ·
AURA $347M -3.1 -29.7% -1601.4% -68.2% ·
CLYM $191M -4.5 · · -34.6% ·
IRWD $550M 22.5 -15.7% 8.1% -8.5% ·
SGMT · -3.7 · · -42.3% ·
CTMX $725M · -44.8% -22.8% -15.9% ·
PRME $626M -2.6 55.3% -4342.4% -221.4% ·
CBIO $327M -24.2 -86.7% -1419.6% -90.0% ·
ALT $400M -3.6 105.0% -214861.0% -45.6% ·
ZURA · · · · · ·
ALLO $314M -1.6 -76.8% · -59.9% ·

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 13, 2026